GC Pharma says picked to import and distribute 40 mln doses of Moderna's vaccine in S.Korea

GC Biopharma

04/03/2021 04:02

SEOUL, March 4 (Reuters) - South Korean drugmaker GC Pharma
 006280.KS  said on Thursday it was picked to import and
distribute 40 million doses of Moderna's COVID-19 vaccine in
South Korea.
    "We are proud to be partnering with the government and
Moderna to support the distribution of crucial vaccines to the
South Korean public," said EC Huh, GC Pharma president in a
statement. 

    
    

 (Reporting by Sangmi Cha; Editing by Jacqueline Wong)
 ((Sangmi.Cha@thomsonreuters.com; +82 2 3704 5646; Reuters
Messaging: sangmi.cha.thomsonreuters.com@reuters.net))